Top Tweets for #LandmarkPaper
#LandmarkPaper: clonal hematopoiesis of indeterminate potential, definition and diagnostic schema published by David Steensma et al. in 2015.
https://t.co/04FMtEQO3U

#LandmarkPaper: In 1965, David Linder and Stanley Gartler demonstrated the hypothesis that cancer might originate from a single cell through a clever experiment on uterine leiomyomas and an X-linked enzyme (G6PD).
https://t.co/Wz9tqxM7JQ

#LandmarkPaper: in 1916, Paul Kaznelson described the first case of splenectomy in a patient with immune thrombocytopenia, thus making splenectomy a life-saving treatment for several thousands of patients.
https://t.co/w0QeUyQUYW

#LandmarkPaper: in 1979, Weiden and colleagues provided the first clear evidence that the human immune system can eradicate cancer through the graft-versus-leukemia effect after allogeneic bone marrow transplantation.
https://t.co/jcK41asg4F

#LandmarkPaper: back to 1994 – the first experimental evidence for the existence of acute myeloid leukemia stem cells.
https://t.co/CuLfsQ4gVX

#LandmarkPaper: 1977, the beginning of the story of allogeneic stem cell transplantation in acute leukemia, the landmark publication in Blood by Donn Thomas and colleagues.
https://t.co/T9jihocYZB

#LandmarkPaper: in 1975 David Galton and John Dacie published a rational proposal of a morphological classification of a multipotential hematopoietic progenitor neoplasm, named “acute myelogenous leukemia”.
https://t.co/hjl42phEAM

#LandmarkPaper: although revised subsequently, the report by Bisel in Blood in 1956 laid the groundwork for the definition of complete remission in acute myeloid leukemia.
https://t.co/XOhM94Weco

#LandmarkPaper: The landmark trial published in 2013 in The New England Journal of Medicineshowed how greatly patients with chronic lymphocytic leukemia benefit from Bruton tyrosine kinase inhibition.
https://t.co/UO9g9GplGU

#LandmarkPaper: thanks to the double-blinded trial VIALE-A, the combination of venetoclax plus azacitidine became the standard of care for older adults with acute myeloid leukemia.
https://t.co/MZwb2TI3qY

#LandmarkPaper: in 2001 Soussain and colleagues described for the very first time the use of thiotepa-based autografting as a consolidation strategy in primary central nervous system lymphoma.
https://t.co/vgXgIB5HoZ

#LandmarkPaper. In 2005, Falini and colleagues published their landmark discovery in The New England Journal of Medicine. They described, for the very first time, cytoplasmic nucleophosmin and NPM1 gene mutation in acute myeloid leukemia.
https://t.co/3oiPjnkXqX

#LandmarkPaper: “Every single patient can teach us important lessons”. What the very first two cases of children with acute lymphoblastic leukemia treated with
#CAR_ T_cells taught us.
https://t.co/cwyR9cee6I

#LandmarkPaper : in 1988, with a new publication in Blood, the history of the treatment of #acutePromyelocyticLeukemia . The authors reported stunning results with the oral vitamin derivative #all-transRetinoicAcid ( #ATRA ).
https://t.co/ssfTSIsl2H

#LandmarkPaper: our approach to the study of the #cancergenome changed in 2008 with the first human #acutemyeloidleukemia genome ever fully sequenced and published in Nature.
https://t.co/lDDH3xa5Yt

#LandmarkPaper: from 1969 to 1991, Fialkow and colleagues, with their brilliant experiments, introduced and demonstrated the important, revolutionary concept of the clonal evolution of #acutemyeloidleukemia.
https://t.co/0bJs6AaRnT

#LandmarkPaper: the International Prognostic Index (IPI), published in 1993 for patients with aggressive B-cell lymphoma, is still the standard for patient prognostication today. https://t.co/9BYGwKLBb6

#LandmarkPaper: in 1976 Bennet and colleagues, the French-British-American cooperative group, introduced for the very first time the term #myelodysplasticSyndrome and the guidelines for its diagnosis and classification
https://t.co/OxTRJFhUmT

#LandmarkPaper: in the treatment of advanced stage aggressive lymphomas, the iconic S8516/0067 trial established #CHOP as a formidable therapeutic backbone that has proved difficult to replace
https://t.co/ElpruZnkSx

#LandmarkPaper: the contribution to treatment intensification and to the birth of the concept of minimal residual disease in #AML by Dr. Arlin, a visionary clinical scientist.
https://t.co/Efb5EEZsnX

Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.6M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.1M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
89.9M followers

Taylor Swift 
@taylorswift13
83.8M followers

Lady Gaga 
@ladygaga
75.3M followers

Virat Kohli 
@imvkohli
73.1M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.1M followers

Bill Gates 
@billgates
65M followers

Selena Gomez 
@selenagomez
62.9M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers
